You are here: Industry Insights > NIH

News List

Spero Therapeutics Receives Grant from NIH americanpharmaceuticalreview
May 05, 2017
Spero Therapeutics announced it has received a grant from the National Institutes of Health (NIH) to conduct additional preclinical studies of SPR720, the company's novel oral bacterial gyrase inhibitor, for the treatment of tuberculosis (TB).
AMRI Wins Five-Year NIH Contract contractpharma
May 03, 2017
To provide drug substance development and manufacturing services
Themis’ live attenuated recombinant Zika vaccine enters human testing fiercepharma
April 12, 2017
Themis is the most recent group to usher a Zika vaccine to the clinic with its live attenuated recombinant candidate, following other efforts by Inovio, the NIH, and a partnership between the Walter Reed Army Institute of Research and Sanofi.
NIH’s Zika vaccine enters phase 2, unscathed by Trump's budget-cutting plans fiercepharma
April 06, 2017
President Donald Trump has proposed $7 billion in spending cuts at the National Institutes of Health, but the agency's Zika vaccine effort won't be among them, at least not yet.
PPD Awarded NIH Contract for HIV Research contractpharma
March 06, 2017
Will support research for HIV that includes monitoring therapeutic trials, prevention trials and vaccines work
NIH begins study of vaccine to protect against mosquito-borne diseases cphi-online
February 24, 2017
Experimental vaccine targets mosquito saliva.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page